NASDAQ: FBIO
Fortress Biotech, Inc.
Healthcare · Biotechnology
After hours: $3.25(-0.61%) · as of 6:14 PM ET
Market Cap
$108.63M
52w High
$4.53
52w Low
$1.77
P/E
0.98
Volume
412.38K
Outstanding Shares
33.22M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 65.15% over the last year. Revenue grew 14.5% over the trailing twelve months. Operating margin moved from -172.27% to -84.36%. Free cash flow grew 311.97% over the trailing twelve months.
What the market seems to be pricing
The stock is trading toward the richer end of its historical P/S range (61st percentile) while business metrics are improving. More of the upside is already embedded in the multiple now.
What would invalidate this read
Operating margin is at -84.36% — continued expansion would be needed to justify the premium. Revenue growth of 14.5% is encouraging, but any deceleration puts the stretched multiple at risk. This read changes if revenue, margins, and cash flow continue to improve faster than expected — in that case the richer multiple could still prove conservative.
Company profile
Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products.
Valuation
Stock splits
Every 15 shares became 1
Profitability & growth
Analyst consensus
6
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 13, 2026
Q3 FY26 · EPS est -$0.20 · Revenue est $18.3M
View